Franz B Humer - Net Worth and Insider Trading
Franz B Humer Net Worth
The estimated net worth of Franz B Humer is at least $750,444 dollars as of 2024-11-05. Franz B Humer is the Director of Allogene Therapeutics Inc and owns about 255,253 shares of Allogene Therapeutics Inc (ALLO) stock worth over $750,444. Details can be seen in Franz B Humer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Franz B Humer has not made any transactions after 2024-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Franz B Humer
Franz B Humer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Franz B Humer owns 3 companies in total, including Allogene Therapeutics Inc (ALLO) , Citigroup Inc (C) , and Kite Pharma Inc (KITE) .
Click here to see the complete history of Franz B Humer’s form 4 insider trades.
Insider Ownership Summary of Franz B Humer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2024-05-30 | director |
| C | Citigroup Inc | 2012-04-17 | director |
| KITE | Kite Pharma Inc | 2017-10-03 | director |
Franz B Humer Latest Holdings Summary
Franz B Humer currently owns a total of 1 stock. Franz B Humer owns 255,253 shares of Allogene Therapeutics Inc (ALLO) as of May 30, 2024, with a value of $750,444.
Latest Holdings of Franz B Humer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2024-05-30 | 255,253 | 2.94 | 750,444 |
Holding Weightings of Franz B Humer
Franz B Humer Form 4 Trading Tracker
According to the SEC Form 4 filings, Franz B Humer has made a total of 1 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 11,200 shares on May 30, 2024, which brought Franz B Humer around $26,208.
Insider Trading History of Franz B Humer
- 1
Franz B Humer Trading Performance
GuruFocus tracks the stock performance after each of Franz B Humer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Franz B Humer is 3.67%. GuruFocus also compares Franz B Humer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Franz B Humer within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Franz B Humer's insider trading performs compared to the benchmark.
Performance of Franz B Humer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.11 | | | | | |
| Relative Return to S&P 500(%) | 0.64 | | | | | |
Franz B Humer Ownership Network
Ownership Network List of Franz B Humer
Ownership Network Relation of Franz B Humer
Franz B Humer Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
Franz B Humer is the director of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, Franz B Humer made 1 insider transaction in Allogene Therapeutics Inc (ALLO) with a net sale of 11,200. Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 37,281 shares made by Deborah M. Messemer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 10,000 shares made by Stephen Mayo .
In summary, during the past 3 months, insiders sold 0 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,481 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,665,846 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
Franz B Humer Mailing Address
Above is the net worth, insider trading, and ownership report for Franz B Humer. You might contact Franz B Humer via mailing address: 388 Greenwich Street, 17th Floor, New York Ny 10013.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
